Bionpharma announced Wednesday the FDA approval of its etravirine tablets, an HIV therapy developed in partnership with STEERLife. The therapy was developed using STEERLife’s proprietary FragMelt continuous processing platform, which enables a sustainable, solvent-free manufacturing process. Precise control: how FragMelt works with heat-sensitive drugs Etravirine is extremely sensitive to heat and shear forces, meaning traditional…
